JR-100 as a Novel Therapeutic Strategy for Tissue Repair in Chronic Neurodegenerative and Inflammatory DiseasesTufts cases: T001848-T000724-T001712Business Opportunity: Mercio (Pereira) Perrin, MD PhD

Tufts University investigators have developed a lithography resist that eliminates minimizes the use of harsh chemicals without sacrificing resolution. Optical-grade silk fibroin aqueous solution

HOMOPOLYMER TAIL MEDIATED LIGATION PCRInventors: David Lazinski and Andrew CamilliTufts Case # T001804InventionDrs. David Lazinski and Andrew Camilli, Tufts University School of Medicine, have

Download a .pdf version of this invention hereSummaryResearchers at Tufts University have developed an injectable silk biopolymer device to treat joint disease which incorporates the 1,2-Dioleoyl-sn

SummaryTufts University researcher, Jeff Hopwood, has developed a low-cost and high-efficiency source that allows plasma surface treatment at atmospheric pressure.SolutionsNon-thermal atmospheric

Identification of a novel therapeutic target for regeneration of the olfactory epitheliumLead Inventor: Dr. James E. SchwobTufts case T001754Business Opportunity: Olfactory dysfunction affects 25% of

Researchers at Tufts University have created a new class of high permeability polymeric membranes with anti-fouling properties. These thin film composite membranes feature a self-assembling copolymer

DESCRIPTIONDr. Charles Mace has designed a novel multilayered paper device. First, liquid sample is transported to chambers within the device with stored reagents. Then the liquid mixtures from the

DESCRIPTIONTufts investigator, Joshua Kritzer, has developed a novel high throughput assay, Chloroalkane Penetration Assay (CAPA), to quantitatively measure the compartment-specific cell penetration

Nanoparticle That Optimizes Singlet Oxygen Detection Singlet oxygen (1O2) is a high-energy form of oxygen and its applications range from photodynamic therapy to biological assays. Tufts University